Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
CordenPharma
CordenPharma
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Manufacturing
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
Design & Build
CordenPharma expands early clinical peptide manufacturing offering
CordenPharma is pleased to announce the commissioning of new GMP capacities at Frankfurt to manufacture early clinical phase peptide APIs for pharma and biotech customers
Manufacturing
CordenPharma launches lipid nanoparticle starter kits
The kits will aid in loss mitigation of high-value payloads during the gene editing journey to market
Research & Development
CordenPharma and pHLIP to develop pHLIP LNP targeted delivery platform for RNA and gene therapies
Manufacturing
CPHI Barcelona Snapshot: CordenPharma
At CPHI Barcelona, Dr Kevin Robinson talked to Dr Michael Quirmbach, CEO and President of CordenPharma, about the company’s recent activities and what lies ahead
Manufacturing
CordenPharma increases peptide production capacity
Following the signature of a multi-year large scale peptide manufacturing agreement earlier this year, CordenPharma has announced the inauguration of increased commercial peptide production capacity with newly-upgraded facilities
Research & Development
CordenPharma creates Technology and Science Advisory Board to drive company forward
The board is comprised of eight renowned experts from academia and industry, who will provide strategic guidance and scientific expertise to drive forward
Subscribe now